CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.35
+0.04 (0.55%)
At close: Feb 26, 2026, 4:00 PM EST
7.35
0.00 (0.00%)
After-hours: Feb 26, 2026, 5:42 PM EST
CorMedix Stock Forecast
Stock Price Forecast
The 7 analysts that cover CorMedix stock have a consensus rating of "Strong Buy" and an average price target of $15.29, which forecasts a 108.03% increase in the stock price over the next year. The lowest target is $12 and the highest is $22.
Price Target: $15.29 (+108.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +90.48% | Feb 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +76.87% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $13 | Buy | Maintains | $22 → $13 | +76.87% | Jan 21, 2026 |
| Needham | Needham | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +104.08% | Jan 8, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +90.48% | Jan 8, 2026 |
Financial Forecast
Revenue This Year
316.32M
from 43.47M
Increased by 627.64%
Revenue Next Year
315.14M
from 316.32M
Decreased by -0.37%
EPS This Year
2.77
from -0.30
EPS Next Year
1.63
from 2.77
Decreased by -41.27%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 326.2M | 330.7M | ||||
| Avg | 316.3M | 315.1M | ||||
| Low | 303.7M | 299.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 650.5% | 4.5% | ||||
| Avg | 627.6% | -0.4% | ||||
| Low | 598.6% | -5.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.08 | 3.05 | ||||
| Avg | 2.77 | 1.63 | ||||
| Low | 2.17 | 1.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 9.9% | ||||
| Avg | - | -41.3% | ||||
| Low | - | -61.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.